QA: PDS Biotechnology Corp in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001472091_2023_PDS_Biotechnology_Corp.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001472091, PDS Biotechnology Corp

  xvar xval
0 AssetsCurrent 76,480,390
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 527,533
4 LiabilitiesCurrent 9,821,036
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 23,184,857
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,241,394
9 ResearchAndDevelopmentExpense 29,431,027
10 remainder_Expenses -1,198,905
11 remainder_Revenues 0
12 remainder_NetIncome -381,339
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 77,007,923
1 Liabilities 33,005,893
2 Expenses 40,473,516
3 Revenues 0
4 StockholdersEquity 44,002,030
5 NetIncome -40,854,855
6 ComprehensiveNetIncome -40,854,855
7 BaseVar 75,434,336
8 EconomicCapitalRatiobeforeLimitedLiability 1.00
9 EconomicCapitalRatio 2.30

Edgar->Model Mapping

Feature Distribution